𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction of proteins with promoter elements of the human U2 snRNA genes in vivo

✍ Scribed by Diana C. Boyd; Ana Pombo; Shona Murphy


Book ID
117521413
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
480 KB
Volume
315
Category
Article
ISSN
0378-1119

No coin nor oath required. For personal study only.

✦ Synopsis


The multicopy human U2 small nuclear (sn)RNA genes are transcribed by RNA polymerase (pol) II and contain two major promoter elements upstream of the transcription start site: an essential proximal sequence element (PSE) at around Γ€55 and a distal sequence element (DSE) at around Γ€220. We have carried out an in vivo footprinting analysis on these genes, and the results suggest that most, if not all, of the U2 gene promoters are bound by factors in interphase. Both the DSE and the PSE are protected from digestion, and the pattern of methylation protection over the DSE is virtually identical to that obtained in vitro using nuclear extract. Our results also indicate that the DNA between the PSE and the transcription start site is distorted and that proteins interact with the promoter between Γ€20 and Γ€33. Mutation of this sequence affects both the accuracy of initiation and polymerase specificity, underlining the importance of this region in U2 gene expression. We have also analysed the pattern of protection over the DSE and PSE of the U2 genes in mitotic cells. The degree of protection over all promoter elements is drastically reduced, suggesting that loss of DNA binding factors from the promoter plays a role in the shutdown of U2 gene transcription in mitosis.


πŸ“œ SIMILAR VOLUMES


Aberrant promoter methylation of human D
✍ Masaaki Yano; Shinichi Toyooka; Kazunori Tsukuda; Hideaki Dote; Mamoru Ouchida; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 767 KB

## Abstract The human DOC‐2/DAB2 interactive protein gene (__hDAB2IP__) is a novel member of the Ras GTPase‐activating gene family that is known to act as a tumor suppressor gene and is inactivated by methylation in prostate and breast cancers. We established previously a methylation‐specific PCR (